FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for Ciclopirox olamine to update labeling and support use for common superficial fungal skin infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Candidiasis
• Tinea Corporis
• Tinea Cruris
• Tinea Pedis
• Tinea Versicolor

Drugs mentioned

• Ciclopirox olamine (Ciclopirox olamine)

Snippet

SUPPL AP for CICLOPIROX OLAMINE (CICLOPIROX OLAMINE)